Cargando…

Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis

BACKGROUND: Diabetic gastroparesis (DG) is a common autonomic neuropathy which impacts on nutritional state and quality of life in diabetic patients, and it also adversely affects glycemic control in diabetes. The prevalence of DG is growing with the number of patients with diabetes continues to inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shengju, Wang, Ruili, Zhang, Yanli, Zhang, Xu, Cai, Baochao, Lu, Yan, Xia, Yuguo, Chen, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249871/
https://www.ncbi.nlm.nih.gov/pubmed/32481350
http://dx.doi.org/10.1097/MD.0000000000020461
_version_ 1783538667112890368
author Wang, Shengju
Wang, Ruili
Zhang, Yanli
Zhang, Xu
Cai, Baochao
Lu, Yan
Xia, Yuguo
Chen, Qiu
author_facet Wang, Shengju
Wang, Ruili
Zhang, Yanli
Zhang, Xu
Cai, Baochao
Lu, Yan
Xia, Yuguo
Chen, Qiu
author_sort Wang, Shengju
collection PubMed
description BACKGROUND: Diabetic gastroparesis (DG) is a common autonomic neuropathy which impacts on nutritional state and quality of life in diabetic patients, and it also adversely affects glycemic control in diabetes. The prevalence of DG is growing with the number of patients with diabetes continues to increase. However, there is no definitive answer as to which of the current therapies is the best for the clinical treatment of the different manifestations of DG. The subject of this study is to answer the following question: what is the best intervention for diabetic patients with gastroparesis? METHODS: Comprehensive searches of the Cochrane Library, PubMed, Embase, Medline, Central and Web of Science, and 4 Chinese databases, including China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals, Chinese Biomedical Literature Database, and WanFang will be completed using the following keywords DG and therapies and related entry terms. Studies will be included, according to the eligibility criteria (randomized controlled trials and controlled clinical trials, considering specific outcome measures for DG). The reference lists of included studies will be manual searched. Relevant data will be extracted from included studies using a specially designed data extraction sheet. Risk of bias of the included studies will be assessed, and the overall strength of the evidence will be summarized through GRADE. A random effects model will be used for all pairwise meta-analyses (with a 95% confidence interval). A Bayesian network meta-analysis will explore the relative benefits between the various therapies. The review will be reported using the Preferred Reporting Items for Systematic Reviews incorporating Network Meta-Analyses statement. Network meta-analysis will be performed using a Bayesian framework through the Winbugs software. RESULTS: This network meta-analysis will identify the best effective therapy for DG. CONCLUSION: This study will compare and evaluate current therapies for DG, and find the best treatment of DG.
format Online
Article
Text
id pubmed-7249871
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72498712020-06-15 Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis Wang, Shengju Wang, Ruili Zhang, Yanli Zhang, Xu Cai, Baochao Lu, Yan Xia, Yuguo Chen, Qiu Medicine (Baltimore) 4300 BACKGROUND: Diabetic gastroparesis (DG) is a common autonomic neuropathy which impacts on nutritional state and quality of life in diabetic patients, and it also adversely affects glycemic control in diabetes. The prevalence of DG is growing with the number of patients with diabetes continues to increase. However, there is no definitive answer as to which of the current therapies is the best for the clinical treatment of the different manifestations of DG. The subject of this study is to answer the following question: what is the best intervention for diabetic patients with gastroparesis? METHODS: Comprehensive searches of the Cochrane Library, PubMed, Embase, Medline, Central and Web of Science, and 4 Chinese databases, including China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals, Chinese Biomedical Literature Database, and WanFang will be completed using the following keywords DG and therapies and related entry terms. Studies will be included, according to the eligibility criteria (randomized controlled trials and controlled clinical trials, considering specific outcome measures for DG). The reference lists of included studies will be manual searched. Relevant data will be extracted from included studies using a specially designed data extraction sheet. Risk of bias of the included studies will be assessed, and the overall strength of the evidence will be summarized through GRADE. A random effects model will be used for all pairwise meta-analyses (with a 95% confidence interval). A Bayesian network meta-analysis will explore the relative benefits between the various therapies. The review will be reported using the Preferred Reporting Items for Systematic Reviews incorporating Network Meta-Analyses statement. Network meta-analysis will be performed using a Bayesian framework through the Winbugs software. RESULTS: This network meta-analysis will identify the best effective therapy for DG. CONCLUSION: This study will compare and evaluate current therapies for DG, and find the best treatment of DG. Wolters Kluwer Health 2020-05-22 /pmc/articles/PMC7249871/ /pubmed/32481350 http://dx.doi.org/10.1097/MD.0000000000020461 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4300
Wang, Shengju
Wang, Ruili
Zhang, Yanli
Zhang, Xu
Cai, Baochao
Lu, Yan
Xia, Yuguo
Chen, Qiu
Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
title Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
title_full Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
title_fullStr Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
title_full_unstemmed Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
title_short Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis
title_sort therapies for diabetic gastroparesis: a protocol for a systematic review and network meta-analysis
topic 4300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249871/
https://www.ncbi.nlm.nih.gov/pubmed/32481350
http://dx.doi.org/10.1097/MD.0000000000020461
work_keys_str_mv AT wangshengju therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT wangruili therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT zhangyanli therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT zhangxu therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT caibaochao therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT luyan therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT xiayuguo therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis
AT chenqiu therapiesfordiabeticgastroparesisaprotocolforasystematicreviewandnetworkmetaanalysis